AU5172690A - Extraction and use of a rna proteo-lipid complex contained in malignant human cells - Google Patents

Extraction and use of a rna proteo-lipid complex contained in malignant human cells

Info

Publication number
AU5172690A
AU5172690A AU51726/90A AU5172690A AU5172690A AU 5172690 A AU5172690 A AU 5172690A AU 51726/90 A AU51726/90 A AU 51726/90A AU 5172690 A AU5172690 A AU 5172690A AU 5172690 A AU5172690 A AU 5172690A
Authority
AU
Australia
Prior art keywords
proteo
rna
extraction
human cells
lipid complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51726/90A
Inventor
Peter Groscurth
Kaspar Rhyner
Andreas Wieczorek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5172690A publication Critical patent/AU5172690A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU51726/90A 1989-03-15 1990-03-12 Extraction and use of a rna proteo-lipid complex contained in malignant human cells Abandoned AU5172690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH95689A CH679246A5 (en) 1989-03-15 1989-03-15
CH956/89 1989-03-15

Publications (1)

Publication Number Publication Date
AU5172690A true AU5172690A (en) 1990-10-09

Family

ID=4199087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51726/90A Abandoned AU5172690A (en) 1989-03-15 1990-03-12 Extraction and use of a rna proteo-lipid complex contained in malignant human cells

Country Status (3)

Country Link
AU (1) AU5172690A (en)
CH (1) CH679246A5 (en)
WO (1) WO1990010872A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002249A1 (en) * 1990-08-08 1992-02-20 Viktor Balazs PROCESS FOR INHIBITING THE FUNCTION OF PROTECTED EXTRA-CELLULAR mRNAs OF CANCEROUS ORIGIN TO PROVIDE PROPHYLAXY AGAINST MALIGNANT DISEASES AND THEIR RELAPSES
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2010079118A1 (en) 2009-01-07 2010-07-15 Michael Roth-Chiarello Use of rna obtained from proteolipid complexes circulating in blood for diagnosis and treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207170A4 (en) * 1984-12-28 1988-06-23 Taisho Pharmaceutical Co Ltd Process for preparing human cancer-specific monoclonal antibody.

Also Published As

Publication number Publication date
CH679246A5 (en) 1992-01-15
WO1990010872A1 (en) 1990-09-20

Similar Documents

Publication Publication Date Title
AU3212689A (en) Medical material permitting cells to enter thereinto and artificial skin
HU904853D0 (en) Enzymes and their use
GB2225764B (en) Improvements in and relating to drug capsules
YU231089A (en) Silicium in powder shape and process for obtaining thereof
AU3938885A (en) Biological preparations and their use
EP0328027A3 (en) Novel soluble polyimidesiloxanes and methods for their preparation and use
AU2614888A (en) Soluble human cd4 fragments and uses therefor
IL90690A0 (en) Tissue equivalents and their preparation
AU8008887A (en) Acrylic copolymer and skin protective
AU1343288A (en) Method and kit for use in conceiving a child of a desired gender
GB9010561D0 (en) Enzymes and their use in drug detection
HK1004564A1 (en) Reactive dyes their preparation and their use
EP0435199A3 (en) Acrylic gel material and acrylic gel preparation
AU6587490A (en) Improvements in and relating to tents
AU3212589A (en) Medical material permitting cells to enter thereinto and artificial skin
AU5172690A (en) Extraction and use of a rna proteo-lipid complex contained in malignant human cells
AU4416189A (en) Therapeutic and diagnostic methods using soluble t cell surface molecules
NZ227594A (en) Human interleukin-1alpha and preparations thereof
AU4494289A (en) Improvements in and relating to catheters
AU5252090A (en) Improvements in and relating to pharmaceutical formulations
GB2225019B (en) Reactive dyes and preparation and use thereof
EP0323645A3 (en) Extract of chlorella and use thereof
AU4935590A (en) Improvements in and relating to moulding techniques
AU7190791A (en) Improvements in and relating to (s)-norfluoxetine
AU7008687A (en) Improvements in and relating to vaccines